Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy
Academic Article
Overview
MeSH Major
Neoplasm Recurrence, Local
Prostate-Specific Antigen
Prostatectomy
Prostatic Neoplasms
Seminal Vesicles
abstract
SVI does not invariably signal BCR or death from cancer in patients who undergo RP and pelvic lymph node dissection. Fifteen years later, approximately 33% of men with SVI and negative lymph nodes are expected remain free of BCR, and CSS was surprisingly good.
